These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4080962)
1. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types]. Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962 [TBL] [Abstract][Full Text] [Related]
2. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization. Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041 [TBL] [Abstract][Full Text] [Related]
3. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer. Björklund V; Björklund B Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380 [TBL] [Abstract][Full Text] [Related]
4. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer]. Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954 [TBL] [Abstract][Full Text] [Related]
5. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer. Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808 [TBL] [Abstract][Full Text] [Related]
6. [The tumor markers TPA and CEA in the after care of breast cancer]. Beaufort F; Fueger GF; Steiner H Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366 [TBL] [Abstract][Full Text] [Related]
7. [Clinical utility of tumor markers in gastric and colon cancer]. Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer]. Ogoshi K; Kondo Y; Akiba Y; Sugihara T; Ko S; Noto T; Makuuchi H; Tajima T; Mitomi T Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966 [TBL] [Abstract][Full Text] [Related]
9. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]. Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629 [TBL] [Abstract][Full Text] [Related]
10. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER]. Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer]. Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770 [TBL] [Abstract][Full Text] [Related]
12. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886 [TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of the clinical use of TPA (tissue polypeptide antigen)]. Dalla Pria AF; Guolo P; Piaserico PL; Ricci G; Berlanda G; Gobbi V; Minello S Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):301-13. PubMed ID: 6680294 [No Abstract] [Full Text] [Related]
14. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance. Lüthgens M; Schlegel G Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393 [TBL] [Abstract][Full Text] [Related]
15. [Association of ferritin with the CEA test in post-operative monitoring of colo-rectal, breast and stomach carcinomas]. Fanciullacci A; Cappetti P; Ciaccio B; Caponi A; Bartoli P; Taviani R; Berti P Quad Sclavo Diagn; 1984 Dec; 20(4):355-63. PubMed ID: 6537546 [TBL] [Abstract][Full Text] [Related]
16. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas. Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692 [No Abstract] [Full Text] [Related]
17. [CEA and TPA in cancer of the breast. Findings and criteria of use]. Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460 [TBL] [Abstract][Full Text] [Related]